2022. Evidence-Based Prioritization and Scoring of Genomic Loci Interacting with Pioglitazone Therapeutic Response in Diabetic Patients. Precision Medicine Communications. 2, 2 (Dec. 2022), 91–108. DOI:https://doi.org/10.55627/pmc.002.02.0188.